Drugmaker Novavax
announced that the company has submitted an application for emergency use authorization of its protein-based COVID-19 vaccine candidate.
| | |
| The Latest on COVID-19 | | | Updated on February 2, 2022 at 1:45 p.m. PST | - Drugmaker Novavax announced that the company has submitted an application for emergency use authorization of its protein-based COVID-19 vaccine candidate.
- Austria will introduce the European Union's strictest COVID-19 vaccine mandate this week: Everyone over 18 years old will be required to be vaccinated against the coronavirus, according to the BBC.
- A U.K. study has shown that exposure to a single nasal droplet containing the coronavirus was enough to cause people to develop COVID-19, according to the Guardian. The trial involved healthy volunteers who were intentionally exposed to the virus.
| | | | FFrom TRANSFORM: Future of Health Day 4 — Mindfulness Tech to Optimize Your Mind. Explore now. | | | | After the Omicron wave passes, here's what experts predict will likely happen in the rest of 2022. | | | Advertisement |  | | Healthy meal prep, simplified with Green Chef | | | Menu variety for plant-powered choices, balanced living, keto, and paleo diets. GET STARTED  | |  | | Advertisement | | Healthy meal prep, simplified with Green Chef | | | | Menu variety for plant-powered choices, balanced living, keto, and paleo diets. | | | | | |
No comments:
Post a Comment
Keep a civil tongue.